A detailed history of Verition Fund Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 364,683 shares of CTLT stock, worth $23.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
364,683
Previous 418,547 12.87%
Holding current value
$23.2 Million
Previous $23.5 Million 6.14%
% of portfolio
0.13%
Previous 0.14%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $3.03 Million - $3.28 Million
-53,864 Reduced 12.87%
364,683 $22.1 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $16 Million - $17 Million
298,777 Added 249.46%
418,547 $23.5 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $5.1 Million - $7.16 Million
119,770 New
119,770 $6.76 Million
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $24,755 - $52,261
777 Added 16.03%
5,624 $243,000
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $220,247 - $359,938
4,847 New
4,847 $318,000
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $425,404 - $664,914
5,879 New
5,879 $425,000
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $406,700 - $531,929
-4,664 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $28,633 - $37,844
-304 Reduced 6.12%
4,664 $517,000
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $594,023 - $690,899
4,968 New
4,968 $636,000
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $553,928 - $722,283
-5,074 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $18,362 - $21,171
-183 Reduced 3.48%
5,074 $549,000
Q1 2021

May 18, 2021

BUY
$101.51 - $125.27 $533,638 - $658,544
5,257 New
5,257 $553,000
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $274,472 - $336,730
-3,196 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $232,477 - $295,630
3,196 New
3,196 $274,000
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $2.81 Million - $3.89 Million
-71,698 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $2.14 Million - $3.15 Million
71,698 New
71,698 $2.91 Million
Q3 2018

Nov 15, 2018

SELL
$40.12 - $45.55 $431,290 - $489,662
-10,750 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$38.72 - $42.52 $416,240 - $457,090
10,750 New
10,750 $450,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.